These include pancreatitis, acute kidney injury, gallbladder disease, and even gastroparesis, a dangerous condition where the stomach essentially becomes paralysed
Benign metastasizing pleomorphic adenoma
GLP-1 agonists were initially approved for treating type 2 diabetes, with subsequent approvals for chronic weight management and reduction of the risk of major cardiovascular events in patients with established cardiovascular disease and type 2 diabetes
Wegovy is an under-the-skin, self-administered injectable prescription medicine for patients with either: A body mass index (BMI) of 30 kg/m2 or greater A BMI of 27 kg/m2 or greater with at least one weight-related ailment such as type 2 diabetes, hypertension, sleep apnea, or others
Also ask about working with a dietitian, as counseling to make the medication even more effective may also be covered